Background Mechanical thrombectomy (MT) is effective in treating ischemic strokes due to
large vessel occlusion. However, the risk‐benefit ratio of intravenous thrombolysis (IVT) prior …

Recent clinical trials have shown that if eligible patients with acute stroke caused by LVO are
rapidly treated with MT, their prospects for independent recovery are significantly improved …

Background Positive pivotal trials followed by guideline endorsement can be a major driver
of change in US national medical practice patterns. We therefore analyzed national trends in …

Acute ischemic stroke (AIS) is a common medical problem associated with significant
morbidity and mortality worldwide. A small proportion of AIS patients meet eligibility criteria …

Thrombolysis and mechanical thrombectomy have revolutionized the care of patients with
acute ischemic stroke. The number of patients who can benefit from these treatments …

Objective The Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) trial was a
multicentre, randomised, controlled clinical trial comparing intravenous thrombolysis (IVT) …

Stroke is the second leading cause of global mortality after coronary heart disease, and a
major cause of neurological disability. About 17 million strokes occur worldwide each year …

Objective To determine outcomes and safety of endovascular treatment for acute ischaemic
stroke, due to proximal intracranial vessel occlusion in the anterior circulation, in routine …

BACKGROUND AND PURPOSE: Mechanical thrombectomy, in addition to intravenous
thrombolysis, has become standard in acute ischemic stroke treatment in patients with large …

Objective and design Whether combining intravenous thrombolysis (IVT) and mechanical
thrombectomy (MT) is superior to mechanical thrombectomy alone for large vessel occlusion …